One study showed that GGT5 is highly expressed in cancer-associated fibroblasts (CAFs) derived from lung adenocarcinoma tissues, and contributes to cancer cell survival and drug resistance (Wei et al., 2020). This evidence concerns the gene GGT5 and lung adenocarcinoma.